Nautilus Biotechnology, Inc.
NAUT
$0.701
$0.03284.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.68% | -1.81% | -11.16% | -16.90% | -19.57% |
| Total Depreciation and Amortization | 2.59% | 4.28% | 11.36% | 26.89% | 41.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.89% | 3.68% | 13.33% | 5.89% | 3.85% |
| Change in Net Operating Assets | -7.58% | -19.98% | -69.59% | -93.08% | -128.06% |
| Cash from Operations | 4.62% | -2.46% | -14.38% | -21.89% | -24.66% |
| Capital Expenditure | 4.42% | -2.38% | -18.02% | -1.02% | -4.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 493.50% | 1,299.67% | 267.42% | 85.06% | 112.42% |
| Cash from Investing | 634.10% | 903.96% | 251.48% | 82.14% | 109.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -16.81% | 49.84% | 210.87% | 282.80% | 160.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.81% | 49.84% | 210.87% | 282.80% | 160.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.00% | 111.97% | 108.68% | 39.22% | 65.17% |